As we enter the second half of 2025, Brevia Health has collected and analysed data on parliamentary discussions surrounding the leading diseases in the UK.
In June 2025, dementia and Alzheimer’s disease took centre stage with a surge in parliamentary interest aligned with national awareness campaigns.
February 2025 was a month marked by World Cancer Day, which sparked a significant increase in discussions around cancer awareness and treatment in the UK Parliament.
Brevia Health’s Disease Profile Tracker offers unique insights into which diseases are being discussed by UK Parliamentarians and advocacy initiatives that can trigger interest.
Throughout 2024, UK parliamentarians discussed prostate cancer consistently; however, the level of interest surged in November, with mentions averaging three times higher than in other months.
Cancer is a relentless disease affecting many lives worldwide and in the UK, it is responsible for more than one in four deaths. Addressing this disease’s fatal and far-reaching outcomes is a priority for governments around the globe.
Brevia Health has appointed Jonathan Mogford to its Advisory Board who brings a career’s experience of health, life sciences and regulation, including more than 10 years corporate executive leadership at MHRA.
Brevia Health has appointed Jonathan Mogford to its Advisory Board who brings a career’s experience of health, life sciences and regulation, including more than 10 years corporate executive leadership at MHRA.
